INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-90 Cr | ₹-71 Cr | ₹-67 Cr | ₹-69 Cr | ₹-37 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDEGENE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-90 Cr |
Mar2024 | ₹-71 Cr |
Mar2023 | ₹-67 Cr |
Mar2022 | ₹-69 Cr |
Mar2021 | ₹-37 Cr |
How is Deferred Tax Assets / Liabilities of INDEGENE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-90 Cr | Negative | |
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-67 Cr | Negative | |
Mar2022 | ₹-69 Cr | Negative | |
Mar2021 | ₹-37 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,640.1 Cr | -1.1% | -4.6% | 2.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -1.1% |
-4.6% |
2.5% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses